ResearcherActive in the last 2 years

N Arnold

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5054315854. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Editor's Note: Thioredoxin Is Downstream of Smad7 in a Pathway That Promotes Growth and Suppresses Cisplatin-Induced Apoptosis in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-4286 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Markus Wolfgang Büchler · 1 shared paper, 2025 · strength 0.30
- Paper Editor's Note: Thioredoxin Is Downstream of Smad7 in a Pathway That Promotes Growth and Suppresses Cisplatin-Induced Ap… DOI 10.1158/0008-5472.can-25-4286 ↗
Murray Korc · 1 shared paper, 2025 · strength 0.30
- Paper Editor's Note: Thioredoxin Is Downstream of Smad7 in a Pathway That Promotes Growth and Suppresses Cisplatin-Induced Ap… DOI 10.1158/0008-5472.can-25-4286 ↗
Helmut Friess · 1 shared paper, 2025 · strength 0.30
- Paper Editor's Note: Thioredoxin Is Downstream of Smad7 in a Pathway That Promotes Growth and Suppresses Cisplatin-Induced Ap… DOI 10.1158/0008-5472.can-25-4286 ↗
Jorg H. Kleeff · 1 shared paper, 2025 · strength 0.30
- Paper Editor's Note: Thioredoxin Is Downstream of Smad7 in a Pathway That Promotes Growth and Suppresses Cisplatin-Induced Ap… DOI 10.1158/0008-5472.can-25-4286 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.